China Resources Pharmaceutical Group Ltd. has announced the formation of a new joint venture fund, the China Resources Pharmaceutical (Chengdu) Innovation Investment Fund Partnership (Limited Partnership), with several parties including Chengdu Runyao Industry Investment Partnership and other independent third parties. The fund is set to have a proposed size of RMB1 billion and a term of seven years. China Resources Pharmaceutical Group Ltd. will have a capital commitment of approximately RMB245 million, representing 24.5% of the total fund. The partnership aims to foster innovation and investment within the pharmaceutical sector.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.